Loading company…
MGC Diagnostics makes cardiorespiratory diagnostic software for lung function and exercise testing.
Founded in 1977 in St. Paul, US, MGC Diagnostics Corporation makes diagnostic software and tools for cardiorespiratory health, including the Ascent software for pulmonary function testing and cardiopulmonary exercise testing. Its customers are hospitals, university medical centers, clinics and research organizations, and it markets products in North America, Europe and parts of Asia. In its most recent fiscal year it reported revenue of USD 40.04 mn and EBITDA of USD -1.24 mn. CAIRE Inc. agreed to acquire the company in November 2022. A Public to Private transaction of USD 50.30 mn was led by Altus Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in